Include | Exclude |
---|---|
All study designs | Reviews |
Primary studies, including peer-reviewed and grey literature | Letters |
All ethnicities | Not about prophylaxis |
Population: Infants born early pre-term up to term, followed up for 1–10 years | Population: Infants with congenital heart defects or lung conditions such as bronchopulmonary dysplasia |
Intervention: RSV prophylaxis with monoclonal antibody | Any other interventions such as RSV Prophylaxis or treatment with RSV-specific immune globulins, steroids, vaccines, macrolides etc. |
Comparison: No prophylaxis or placebo | Comparison: Different dosing regimen of monoclonal antibody |
Outcome: Recurrent wheeze or asthma development | Bronchiolitis caused by other allergens or viruses such as rhinovirus |